This article may be too technical for most readers to understand.(May 2023) |
| |||
Names | |||
---|---|---|---|
IUPAC name
1-Methyl-3-(2-methylpropyl)-7H-purine-2,6-dione
| |||
Other names
3-Isobutyl-1-methylxanthine
| |||
Identifiers | |||
3D model (JSmol)
|
|||
ChEBI | |||
ChEMBL | |||
ChemSpider | |||
DrugBank | |||
ECHA InfoCard | 100.044.767 | ||
KEGG | |||
PubChem CID
|
|||
UNII | |||
CompTox Dashboard (EPA)
|
|||
| |||
| |||
Properties | |||
C10H14N4O2 | |||
Molar mass | 222.3 g/mol | ||
Appearance | White solid | ||
Melting point | 199 to 201 °C (390 to 394 °F; 472 to 474 K) | ||
Solubility | Soluble in ethanol, DMSO, and methanol | ||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
IBMX (3-isobutyl-1-methylxanthine), like other methylxanthine derivatives, is both a:
As a phosphodiesterase inhibitor, IBMX has IC50 = 2–50 μM[6] and does not inhibit PDE8 or PDE9.[7]
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search